CTIS2023-505919-21-00招募中1 期
A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986435/MYK-224 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF) - CV029-1001
Bristol-Myers Squibb Services Unlimited Company0 个研究点目标入组 55 人开始时间: 2023年11月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Adult patients with stable, symptomatic HFpEF with a normal heart pumping ability.
排除标准
- •Some key exclusion criteria include: patients must not have a known diagnosis of obstructive or genetic hypertrophic cardiomyopathy or infiltrative/storage disorder such as cardiac amyloidosis, or any other acute or serious condition that could interfere with assessments during the study or may pose a risk to the participant.
研究者
相似试验
进行中（未招募）
1 期
A study to assess if a new antiviral drug called FF-3 is safe and can protect healthy volunteers against infection with a type of flu virus.EUCTR2015-001103-31-GBAutoimmune Technologies, LLC79
进行中（未招募）
1 期
Study of the effect of ASP6294 for the treatment of Bladder Pain Syndrome/Interstitial Cystitis in female subjects.Bladder Pain Syndrome/Interstitial Cystitis (BPC/IC)MedDRA version: 20.0 Level: LLT Classification code 10071166 Term: Bladder pain syndrome System Organ Class: 100000004857EUCTR2016-004138-12-BEAstellas Pharma Europe B.V.163
进行中（未招募）
1 期
A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR MutatioMedDRA version: 19.0 Level: PT Classification code 10011762 Term: Cystic fibrosis System Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2015-004841-13-FRVertex Pharmaceuticals Inc.142
进行中（未招募）
1 期
A clinical study to evaluate safety, tolerability, Pharmacokinetics and Pharmacodynamis of Belcesiran in patients with PiZZ Alpha-1 Antitrypsin Deficiency.PiZZAlpha-1 Antitrypsin Deficiency Associated Liver DiseaseMedDRA version: 23.1Level: LLTClassification code 10001806Term: Alpha-1 anti-trypsin deficiencySystem Organ Class: 100000004850EUCTR2020-003313-35-ESDicerna Pharmaceuticals, Inc.54
进行中（未招募）
不适用
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study to Evaluate the Efficacy and Safety of CAT-354, a Fully Human Monoclonal Antibody Directed Against Interleukin-13 (IL-13), on Asthma Control in Adults with Uncontrolled, Moderate-to-severe, Persistent AsthmaAsthmaMedDRA version: 8.1Level: PTClassification code 10003553Term: AsthmaEUCTR2008-007844-33-DEMedImmune Limited192